Potent Antiviral Activity of Vitamin B12 against Severe Acute Respiratory Syndrome Coronavirus 2, Middle East Respiratory Syndrome Coronavirus, and Human Coronavirus 229E
Authors:
- Yassmin MoatasimYMYassmin Moatasim
- Omnia KutkatOKOmnia Kutkat
- Ahmed M. OsmanAhmed M. Osman
- Mokhtar R. GomaaMGMokhtar R. Gomaa
- Faten OkdaFaten Okda
- Mohamed El SayesMSMohamed El Sayes
- Mina Nabil KamelMKMina Nabil Kamel
- Mohamed GaballahMGMohamed Gaballah
- Ahmed MostafaAhmed Mostafa
- Rabeh El-SheshenyRabeh El-Shesheny
- Ghazi KayaliGhazi Kayali
- Mohamed A. AliMAMohamed A. Ali
Open Access
- 15 November 2023
- journal article
- research article
- Published by MDPI AG in Microorganisms
- Vol. 11 (11) , 2777
Abstract
Repurposing vitamins as antiviral supporting agents is a rapid approach used to control emerging viral infections. Although there is considerable evidence supporting the use of vitamin supplementation in viral infections, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the specific role of each vitamin in defending against coronaviruses remains unclear. Antiviral activities of available vitamins on the infectivity and replication of human coronaviruses, namely, SARS-CoV-2, Middle East respiratory syndrome coronavirus (MERS-CoV), and human coronavirus 229E (HCoV-229E), were investigated using in silico and in vitro studies. We identified potential broad-spectrum inhibitor effects of Hydroxocobalamin and Methylcobalamin against the three tested CoVs. Cyanocobalamin could selectively affect SARS-CoV-2 but not MERS-CoV and HCoV-229E. Methylcobalamin showed significantly higher inhibition values on SARS-CoV-2 compared with Hydroxocobalamin and Cyanocobalamin, while Hydroxocobalamin showed the highest potent antiviral activity against MERS-CoV and Cyanocobalamin against HCoV-229E. Furthermore, in silico studies were performed for these promising vitamins to investigate their interaction with SARS-CoV-2, MERS-CoV, and HCoV-229E viral-specific cell receptors (ACE2, DPP4, and hAPN protein, respectively) and viral proteins (S-RBD, 3CL pro, RdRp), suggesting that Hydroxocobalamin, Methylcobalamin, and Cyanocobalamin may have significant binding affinity to these proteins. These results show that Methylcobalamin may have potential benefits for coronavirus-infected patients.Keywords
Funding Information
- National Institute of Allergy and Infectious Diseases (HHSN272201400006C, 12010125)
- National Research Centre (HHSN272201400006C, 12010125)
This publication has 84 references indexed in Scilit:
- Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4Cell Research, 2013
- Vitamin D: An innate antiviral agent suppressing hepatitis C virus in human hepatocytesHepatology, 2011
- Vitamin D supplementation improves response to antiviral treatment for recurrent hepatitis CTransplant International, 2010
- Vitamin B12: the forgotten micronutrient for critical careCurrent Opinion in Clinical Nutrition and Metabolic Care, 2010
- Epidemiology and Clinical Presentations of the Four Human Coronaviruses 229E, HKU1, NL63, and OC43 Detected over 3 Years Using a Novel Multiplex Real-Time PCR MethodJournal of Clinical Microbiology, 2010
- Vitamin D Decreases Respiratory Syncytial Virus Induction of NF-κB–Linked Chemokines and Cytokines in Airway Epithelium While Maintaining the Antiviral StateThe Journal of Immunology, 2009
- Identification of critical active‐site residues in angiotensin‐converting enzyme‐2 (ACE2) by site‐directed mutagenesisThe FEBS Journal, 2005
- Noncalcemic Actions of Vitamin D Receptor LigandsEndocrine Reviews, 2005
- Structure validation by Cα geometry: ϕ,ψ and Cβ deviationProteins: Structure, Function, and Bioinformatics, 2003
- Comparative Protein Modelling by Satisfaction of Spatial RestraintsJournal of Molecular Biology, 1993